Every year, skincare trends promise something new. Doctors tend to ask a different question: what actually matters now, and what still delivers long-term results? In 2026, effective skincare is defined less by novelty and more by how emerging technologies have earned their place alongside proven clinical actives. This guide covers the seven categories doctors are actively using and recommending — not because they are fashionable, but because they serve clear, distinct roles in modern treatment strategies.

1. GLP-1–related facial skin changes

GLP-1 medications (semaglutide, tirzepatide) have changed the skincare landscape in a clinically significant way. Doctors are increasingly seeing patients who are pleased with systemic results but concerned about changes in facial skin quality — increased crepiness or fragility, reduced skin elasticity and bounce, and a more aged appearance following rapid weight change.

This presentation is now common enough to be considered a distinct clinical context. Skincare cannot replace facial volume in the way aesthetic procedures can, but it can meaningfully address what is addressable: skin quality and surface resilience, barrier integrity during metabolic change, hydration, and the appearance of fine textural ageing. GLP-1–context skincare is a legitimate and growing category focused on protecting skin quality in a physiologically new situation.

See our articles on GLP-1 facial volume loss and addressing Ozempic face with VOL.U.LIFT for more detail.

2. Advanced peptides

Peptides are no longer treated as secondary or cosmetic add-ons. In 2026, doctors increasingly rely on advanced peptide blends as a core part of routines focused on skin quality, tolerance, and recovery. Modern formulations combine multiple peptides with distinct roles — tripeptides and hexapeptides for collagen signalling, copper peptides for repair and regeneration, acetyl tetrapeptides for barrier and neuromodulatory effects.

What has changed is not the concept of peptides, but how they are used. Doctors now use them to support skin resilience alongside stronger actives, reduce irritation trade-offs, and maintain skin quality when prescription treatments are paused or unsuitable. Peptides do not replace retinoids — they enable consistency, which in practice often determines outcomes.

See our complete guide to peptides in skincare for a full breakdown of types and mechanisms.

3. Exosomes

Exosomes represent a newer class of skincare focused on cell signalling and recovery rather than exfoliation or stimulation. In 2026, doctors are using exosome-based skincare selectively — as a supportive layer for skin quality and recovery, alongside established actives rather than instead of them. They are positioned as adjunctive tools where skin resilience and repair are priorities, particularly in sensitised, post-procedure, or stressed skin.

Formulation quality, sourcing, and realistic expectations remain essential. See our complete science guide to exosomes for a detailed explanation of how they work.

4. Tretinoin

Despite the rise of newer categories, tretinoin remains unmatched for measurable improvements in fine lines and texture, acne, and uneven pigmentation. It is the most extensively studied topical retinoid available and the gold standard prescription retinoid for most indications.

What has evolved in 2026 is not the active itself, but how it is prescribed and supported — lower-irritation introduction protocols, improved formulation vehicles, and better integration with complementary actives (peptides, barrier support, vitamin C) that improve tolerability and long-term consistency. Tretinoin used correctly and consistently over 12+ months produces results that no OTC alternative can match.

See our beginner's guide to starting tretinoin and our UK buying guide for more detail.

5. Retinol and modern retinoids

Retinol remains the most widely used OTC retinoid and a clinically meaningful option for those not yet on prescription treatment. In 2026, the retinoid landscape has expanded — retinaldehyde (retinal) has gained significant traction as a more potent OTC option, one conversion step from retinoic acid and significantly more effective than retinol at equivalent concentrations.

The EU retinol concentration cap (0.3% maximum in face products from May 2027) has accelerated interest in retinaldehyde as an alternative for those who were relying on higher-strength OTC retinol. For those who have plateaued on OTC retinoids, prescription tretinoin remains the logical next step.

See our complete guide to retinol and our article on the EU retinol regulation for more detail.

6. Hyperpigmentation treatments: why hydroquinone still matters

Hydroquinone 4% remains the most clinically substantiated topical treatment for hyperpigmentation and melasma — and in 2026, it remains the benchmark against which alternatives are measured. The combination of prescription tretinoin and hydroquinone 4% (as used in the Obagi Nu-Derm system) is the most effective topical protocol available for stubborn pigmentation.

The growing interest in hydroquinone alternatives — tranexamic acid, niacinamide, azelaic acid, alpha arbutin — reflects the practical constraints of hydroquinone (prescription-only, cycling required, not suitable during pregnancy) rather than any clinical superiority of the alternatives. For most patients with significant pigmentation, hydroquinone remains the most appropriate first-line prescription treatment.

See our medical-grade skincare routine for hyperpigmentation and our guide to hydroquinone alternatives for full protocols.

7. SPF 50: the non-negotiable foundation

Daily broad-spectrum SPF 50 is not a trend — it is the single most important step in any skincare routine, and the one most consistently underused. UV exposure is the primary driver of photoageing, the primary aggravating factor in melasma, and the factor that counteracts the effects of every other active in this list. No topical treatment can compensate for inadequate sun protection.

In 2026, the standard is SPF 50 broad-spectrum, applied every morning as the final step of the routine, reapplied every 2 hours when outdoors. SPF 30 is no longer considered adequate for patients using prescription actives.